Can You Take Ritonavir and Midazolam Together?

No. According to the U.S. FDA drug label for ritonavir, the combination of ritonavir and orally administered midazolam is contraindicated—meaning the drugs should not be taken together. The interaction carries a documented risk of prolonged or increased sedation and respiratory depression. Even parenteral (injected) midazolam requires close clinical monitoring and possible dose reduction when used with ritonavir, and should only be given in a controlled medical setting.

What the Source Says

The source controlling this article is the FDA-approved prescribing information for ritonavir. The label explicitly states that orally administered midazolam and triazolam are contraindicated because of the potential for prolonged or increased sedation or respiratory depression. For parenteral midazolam (administered by injection or infusion), the label takes a slightly less absolute stance but still emphasizes significant risk: co-administration should occur only in a setting with close clinical monitoring and appropriate medical management capability in case of respiratory depression or prolonged sedation. The label also notes that dosage reduction for midazolam should be considered, especially if more than a single dose is administered.

This recommendation appears in the FDA label under the section addressing sedative and hypnotic drug interactions. The source record does not specify the underlying pharmacological mechanism, but the label's explicit severity designation—contraindicated for oral midazolam, conditional with monitoring for parenteral midazolam—reflects the seriousness with which the FDA and ritonavir manufacturers view this pair.

How to Understand This

To understand why this interaction is so serious, it helps to know what each drug does and how they relate to each other in the body.

Ritonavir's role: Ritonavir is a protease inhibitor, a class of antiretroviral drugs used to treat HIV infection. Beyond its direct antiviral effect, ritonavir is widely used at low doses as a pharmacokinetic booster in combination antiretroviral regimens because of its potent effect on drug-metabolizing enzymes in the liver and intestine.

Midazolam's role: Midazolam is a benzodiazepine sedative and hypnotic. It is commonly used for pre-operative sedation, procedural sedation (such as before endoscopy), anxiety management, and in some cases as a sleep aid. The drug works by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA), which depresses central nervous system activity, producing sedation, muscle relaxation, and anxiolytic effects.

Why the interaction matters: Ritonavir potently inhibits certain liver enzymes responsible for metabolizing many drugs, particularly the cytochrome P450 system. Although the source record does not specify the exact mechanism of this particular interaction, the clinical consequence is well-documented: when ritonavir is present, midazolam levels in the blood can rise significantly and persist longer than expected. This elevated and prolonged exposure to midazolam increases the risk that sedation will be deeper or last longer than intended, and it raises the risk of respiratory depression—a serious condition in which breathing becomes dangerously shallow or slow.

Why oral midazolam is more problematic: The FDA label distinguishes between orally administered midazolam (which is contraindicated) and parenteral midazolam (which requires monitoring). This distinction reflects the fact that orally administered drugs are absorbed through the gastrointestinal tract and pass through the liver before entering the general circulation—a process called first-pass metabolism. Ritonavir's enzyme-inhibiting effect is particularly pronounced on first-pass metabolism, so oral midazolam is affected more dramatically than parenteral forms, which bypass some of this hepatic processing.

General pharmacology context: Benzodiazepines as a class have a narrow therapeutic window, meaning the difference between an effective dose and a dangerous dose is not large. When a drug that interferes with benzodiazepine metabolism is added, the risk of oversedation and respiratory compromise rises sharply. This is especially true in vulnerable populations such as older adults, those with liver or kidney disease, or patients with underlying respiratory conditions, although the FDA label's contraindication applies regardless of individual risk factors.

Who Should Pay Particular Attention

The FDA label's contraindication for oral midazolam applies to all patients taking ritonavir, without exception based on age, weight, or comorbidity. However, certain patients may be at higher risk of serious harm if the contraindication is not observed:

• Patients with underlying respiratory disease (such as chronic obstructive pulmonary disease or sleep apnea), who are more vulnerable to respiratory depression
• Older adults, who tend to be more sensitive to benzodiazepines and have reduced drug clearance
• Patients with liver impairment, who may clear both drugs more slowly
• Patients already taking other sedating or respiratory-depressant medications (such as opioids or other central nervous system depressants)

If parenteral midazolam is deemed medically necessary despite ritonavir therapy, these same groups require heightened vigilance during the procedure or infusion.

Hypothetical Example 1: Oral Midazolam

Consider a patient taking ritonavir as part of an HIV treatment regimen who is scheduled for a dental procedure and is given oral midazolam to take before the appointment. According to the FDA label, this combination is contraindicated. The midazolam would be absorbed from the mouth and stomach and then pass through the liver, where ritonavir would inhibit its metabolism. Instead of reaching expected blood levels and then gradually declining, the midazolam levels would remain elevated and peak higher than normal. The patient might experience sedation that is deeper than anticipated, that lasts much longer, or that includes respiratory depression that is difficult to reverse. Because the patient took the dose at home before the procedure, medical personnel would not be immediately available to manage these risks.

Hypothetical Example 2: Parenteral Midazolam in a Controlled Setting

Now consider a different scenario: the same patient needs an inpatient procedure (such as a colonoscopy) and the medical team decides to use parenteral midazolam for sedation. The FDA label does not absolutely contraindicate this but requires that it occur in a monitored setting with capability to manage respiratory depression. The patient would receive midazolam by injection, and because it bypasses some first-pass hepatic metabolism, the peak elevation in blood levels might not be as extreme as with oral administration. However, ritonavir would still inhibit the drug's clearance, so the sedation could be prolonged. The clinical team would monitor the patient's oxygen saturation, respiratory rate, and level of consciousness throughout and afterward, and would have resuscitation equipment and reversal agents (such as flumazenil) immediately available. The team might also reduce the dose of midazolam compared to what would be used in a patient not taking ritonavir. This scenario illustrates how medical management and monitoring can mitigate—but not eliminate—the interaction risk.

What to Discuss With a Pharmacist or Physician

If you take ritonavir and believe you need a sedative, anxiolytic, or sleep aid, or if you are facing a procedure that typically requires sedation, have a detailed conversation with your prescriber and pharmacist:

• Ask about the interaction: "I take ritonavir. Are there any sedatives or sleep aids I should avoid?" Make sure your prescriber is aware of the ritonavir in your regimen.
• Discuss alternatives: "Are there sedatives or anxiolytics that interact less with ritonavir, or are there non-medication approaches for this situation?" Your pharmacist can review which benzodiazepines or other sedatives are safer alternatives.
• If a procedure requires sedation: "I'm taking ritonavir. What sedation options do you have for patients with this medication, and how will you monitor me?" Ensure the facility is equipped for procedural sedation and monitoring.
• Verify your full medication list: Bring all your medications (including over-the-counter drugs, supplements, and herbal products) to your appointments. Other drugs may also interact with ritonavir or midazolam.
• Do not adjust doses on your own: Never skip, reduce, or stop ritonavir to "allow" midazolam use, and never increase midazolam doses to compensate for ritonavir's effects. All dose decisions must come from your physician based on your individual clinical situation.

Key Takeaways

• Ritonavir and orally administered midazolam are contraindicated according to the FDA drug label—they should not be used together due to risk of prolonged sedation and respiratory depression.
• Parenteral (injected) midazolam is not absolutely contraindicated with ritonavir but requires administration in a monitored clinical setting with capability to manage respiratory depression and may require dose reduction.
• The FDA label does not specify the exact mechanism, but ritonavir is a potent inhibitor of liver drug-metabolizing enzymes, which causes midazolam to accumulate to higher-than-expected levels.
• Oral forms of midazolam are more severely affected by ritonavir than injected forms because of the way the liver processes orally administered drugs.
• If you take ritonavir and need sedation or are scheduled for a procedure, discuss with your pharmacist and physician what alternatives exist and how any necessary sedation will be managed safely.

Sources

• DailyMed—Official FDA drug labels and information
• OpenFDA—Searchable FDA drug and device data
• RxNorm—NIH/NLM standardized drug naming and identifiers
• PubMed—Biomedical literature database

This article is an educational explanation of source material from the FDA-approved prescribing label for ritonavir. It is not a substitute for professional medical advice. Before starting, stopping, or changing any medication, always confirm your choices with a pharmacist or physician who knows your full medical history. If you take multiple medications, use checkdruginteractions.com to check your medication list for documented interactions, and bring those results to your healthcare provider for discussion.